NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

A day without DCVax-L is like a day without sunshine!
Maybe NWBO can get Anita Bryant to do their first commercial on approval. Since DCVax has such a great safety profile, once it’s a first line treatment, it won’t have the buzz kill list of potential side effects that most drugs have.

Thanks for sharing this, John! No doubt dendritic cell vaccines will be the cornerstone of cancer treatment in the future. There is much still to overcome to make that a reality, but the possibility of beginning to realizing it seems close at hand with DCVax-L.